In the News
-
Twin Cities Doctors Experiment with a Single Price, Single Bill for Surgery
The Star Tribune, 23 April 2013Rajeev Kapoor, A.T. Kearney partner, discusses the Affordable Care Act and its efforts to make health care more patient-friendly and cost-effective.
-
Outcomes-Driven Models Will Change Retail Rx
Chain Drug Review, 22 April 2013Express Scripts Inc. and Walgreen Co. highlight the zero-sum nature of the traditional relationship between retailers and payers; the new approach will trigger massive upstream changes in health care that will alter the very role of pharmacies.
©2013 Chain Drug Review, Racher Press -
A Better Way to Engage with Suppliers
Supply Chain Quarterly, Q4 2012This article discusses the three step process for supplier segmentation, supplier-specific action plans, and the rules of engagement in order to better develop and maintain collaborative relations with far-flung suppliers.
-
The Shift Towards Wellness—An Exclusive Interview With Rajeev Kapoor
Engage Healthcare Today, 21 February 2013Rajeev Kapoor shares his insights on the changes currently occurring within the American healthcare system, what's causing them, and the technologies that are helping to drive them.
-
Older Consumers Need Friendlier Packaging
Chain Drug Review, July 15 2012Today, packaging for retail is more than choosing paper, shrink wrap, color, and fonts. It also requires thinking about aging consumers and then rethinking everything you know about product presentation.
-
Retail Art, Science Needed to Reach Mature Consumers
Chain Drug Review, 25 June 2012Selling to mature consumers requires a new taxonomy—one that uses smaller and smaller sub-segments to gain a better understanding of their needs.
-
A.T. Kearney Releases Report Designed to Help Achieve Stakeholder Confidence in Mobile Health
13 November 2012Healthcare will always be a challenge as a result of rising costs, access, barriers to reform, and power struggles. Mobile health aims to lower cost interactions, provide increased access, and add value through up-to-date diagnosis and prevention.
-
Mobile Health—How to Make It Pay
November 2011Mobile health (mHealth) offerings promise to improve healthcare delivery and provide revenue for service providers—but adoption and monetizing the opportunity will require changes to the way the industry does business.
-
A Collaborative Strategy Aims to Enhance Care for Seniors
Chain Drug Review, 27 August 2012Retail pharmacy and other health care professionals are rapidly adopting virtual integration to manage chronic diseases and improve standards
-
Mature Consumers to Shape the Future of Retail Pharmacy
Chain Drug Review, 23 April 2012What are the most important opportunities and challenges that the mature consumer presents to retail pharmacy operators?
-
Mature Consumers Empowered by Technology
Chain Drug Review, 21 May 2012Expert data analysis and technology-enabled personalized services will help drug stores give mature shoppers the personal touch they expect.
-
Mature Consumers: What Drug Chains Need to Know
Chain Drug Review, 21 November 2011As this customer group grows and gains purchasing power, smart companies will adjust their strategies accordingly.
-
Pharmaceuticals out of Balance: Reaching the Tipping Point
21 September 2009A.T. Kearney presents evidence that the current pharmaceutical model may become irrelevant in the context of 21st century's global healthcare needs. With the current dialogue on healthcare reform and the healthcare system in urgent need of restructuring, there is a commensurate impact on the pharmaceutical industry.
-
Farming Out Pharma
Chaina, November/December 2010China's pharma cost advantage will erode as inflation rises, currency appreciates, and tax rebate structures evolve.
-
How to Unlock $43 Billion by Improving Working Capital Management
PharmaPro, April 2010Pharmaceuticals can save billions to invest in value-generating initiatives.
-
Will China Lose Its Cost-Competitiveness in Pharma Manufacturing?
Life Science Leader, September 2010As China's pharmaceutical manufacturing market evolves, Western companies must choose among solutions with varying degrees of complexity and reward.
-
In the Eye of the Beholder: of Values & Value - 2
eyeforpharma.com, 5 November 2009Pharma Expert Contributor, Fatima Moncrieffe, explores the concept of value in the pharmaceutical industry, referring to A.T. Kearney's research and experts, who explain that the current U.S. debate is a critical issue for the entire world.
-
Pharma at the Tipping Point III: From R&D to Markets
eyeforpharma.com, 21 October 2009Healthcare demand is shifting rapidly toward the developing world, where 96% of global population growth is expected over the next 50 years. For pharmas faced with pricing pressures in developed markets, emerging markets will become too attractive to continue to ignore, and pharmas, A.T. Kearney says, will need to establish prices in a way that maximizes revenue over a drug's entire lifecycle and across global markets.
-
Pharma at the Tipping Point II: Emerging Markets
eyeforpharma.com, 21 October 2009Healthcare demand is shifting rapidly toward the developing world, where 96% of global population growth is expected over the next 50 years. For pharmas faced with pricing pressures in developed markets, emerging markets will become too attractive to continue to ignore, and pharmas, A.T. Kearney says, will need to establish prices in a way that maximizes revenue over a drug's entire lifecycle and across global markets.
-
Pharma at the Tipping Point I: Price Versus Value
eyeforpharma.com, 21 October 2009Why is the industry operating on the precipice? A.T. Kearney observes that even as healthcare budgets are rising, drug sales in most developed countries are forecast to be flat. Pricing pressures are increasing globally, and even the normally safe haven of the U.S. has become a challenging market. The problems, A.T. Kearney says, are symptoms of a shift in the nature of healthcare systems.
In the News
Global Leaders
Europe, Middle East, and Africa
Asia Pacific
Global
Americas